JEST
PRCT icon

JTC Employer Solutions Trustee’s Procept Biorobotics PRCT Stock Holding History

JTC Employer Solutions Trustee’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18K Hold
810
– – ﹤0.01% 280
2026
Q1 		$20K Hold
810
– – ﹤0.01% 271
2025
Q4 		$25K Hold
810
– – ﹤0.01% 270
2025
Q3 		$30K Buy
+810
New +$37K ﹤0.01% 263

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JTC Employer Solutions Trustee's PRCT Position: Q2 2026 in Review

JTC Employer Solutions Trustee held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 810 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #280.

JTC Employer Solutions Trustee first reported a position in PRCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $30K in Q3 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • JTC Employer Solutions Trustee held 810 shares of Procept Biorobotics worth $18K as of Q2 2026.
  • JTC Employer Solutions Trustee left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of JTC Employer Solutions Trustee's portfolio in Q2 2026, its #280 holding.
  • JTC Employer Solutions Trustee first reported a position in Procept Biorobotics in Q3 2025 and has held it in 4 quarters since.
  • JTC Employer Solutions Trustee's Procept Biorobotics position peaked at $30K in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q2 2026, filed 31 Jul 2026.